Therapeutics: RAR-related orphan receptor C (RORC; RORγ)

Cancer

INDICATION: Prostate cancer

Patient sample, cell culture and mouse studies suggest inhibiting RORC could help treat castration-resistant prostate cancer (CRPC).

Read the full 196 word article

User Sign In

Article Purchase

This article may not be distributed to non-subscribers

PURCHASE THIS ARTICLE FOR LIMITED ONE-TIME DISTRIBUTION AND WEBSITE POSTING $995.00 USD

PURCHASE